Cetera Advisor Networks LLC Bio Rad Laboratories, Inc. Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $80,893 - $93,629	-266 Reduced 28.48%	668 $231,000
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $303,310 - $411,035	-1,126 Reduced 54.66%	934 $301,000
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $1,751 - $2,113	5 Added 0.24%	2,060 $738,000
Q2 2023 Aug 09, 2023	BUY	$359.49 - $486.4 $18,693 - $25,292	52 Added 2.6%	2,055 $779,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $29,726 - $35,713	71 Added 3.67%	2,003 $959,000
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $679,503 - $881,011	1,932 New	1,932 $812,000
Q3 2020 Nov 13, 2020	SELL	$454.43 - $535.6 $91,340 - $107,655	-201 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $67,308 - $99,105	201 New	201 $91,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.